Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding
Open Access
- 16 March 2015
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 67 (7) , 1881-1890
Abstract
Objective: Endothelial cell (EC) damage in systemic sclerosis (SSc) is reflected by the shedding of microparticles (MPs). The aim of this study was to show that inhibiting MP release using pantethine or by inactivating ATP‐binding cassette transporter A1 (ABCA1) ameliorates murine SSc.Methods: First, the effects of pantethine on MP shedding and on basal oxidative and nitrosative stresses in ECs and fibroblasts were determined in vitro. The effects of pantethine were then tested in vivo. SSc was induced in BALB/c mice by daily intradermal injection of HOCl. Mice were simultaneously treated daily with pantethine by oral gavage.Results: In vitro, pantethine inhibited MP shedding from tumor necrosis factor–stimulated ECs and abrogated MP‐induced oxidative and nitrosative stresses in ECs and fibroblasts. Ex vivo, pantethine also restored redox homeostasis in fibroblasts from mice with SSc. In vivo, mice with SSc displayed skin and lung fibrosis associated with increased levels of circulating MPs and markers of oxidative and endothelial stress, which were normalized by administration of pantethine or inactivation of ABCA1.Conclusion: Pantethine is a well‐tolerated molecule that represents a potential treatment of human SSc.Keywords
Funding Information
- European Union Seventh Framework Programme (FP7/2007-2013, 215009)
- Université Paris Descartes
- Assistance Publique-Hôpitaux de Paris AP-HP
- RedCat
This publication has 33 references indexed in Scilit:
- Early Vascular Alterations in SLE and RA Patients—A Step towards Understanding the Associated Cardiovascular RiskPLOS ONE, 2012
- Arsenic Trioxide Prevents Murine Sclerodermatous Graft-versus-Host DiseaseThe Journal of Immunology, 2012
- The organotelluride catalyst LAB027 prevents colon cancer growth in the miceCell Death & Disease, 2011
- Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular InjuryPLOS ONE, 2010
- Pantethine rescues a Drosophila model for pantothenate kinase–associated neurodegenerationProceedings of the National Academy of Sciences, 2010
- Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic SyndromeThe American Journal of Pathology, 2008
- The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosisArthritis & Rheumatism, 2008
- Protection against cerebral malaria by the low-molecular-weight thiol pantethineProceedings of the National Academy of Sciences, 2008
- Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosisAnnals of the Rheumatic Diseases, 2007
- Effect of Oral Treatment with Pantethine on Platelet and Plasma Phospholipids in IIa HyperlipoproteinemiaAngiology, 1987